THE Australian Self-Medication
Industry has joined the
Complementary Healthcare Council
(PD yesterday) in encouraging
health professionals to consider
the research linking omega-3 and
prostate cancer alongside “preexisting
robust evidence that
demonstrates the positive health
benefits of fish oil”.
ASMI said it believes that the
widely publicised study findings
linking omega-3 to prostate cancer
are inconclusive, and therefore
“they do not warrant any changes
to the way in which omega-3
supplements are used”.
“The study findings indicate
an association, but do not
demonstrate cause and effect,” said
ASMI’s Steve Scarff.The above article was sent to subscribers in Pharmacy Daily's issue from 16 Jul 13 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 16 Jul 13
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.